Former President Donald Trump is reportedly planning to instruct his administration to reclassify marijuana as a less dangerous drug. The move signals a significant shift in U.S. drug policy and could potentially impact federal regulations on cannabis.
Sources familiar with the matter indicate that this reclassification could pave the way for broader legalization efforts and reduce federal enforcement against marijuana-related activities. The proposal has garnered attention from industry stakeholders and advocates, who see it as a step toward broader acceptance and regulatory reform.
Following early reports of the potential policy change, shares of cannabis companies experienced a notable surge in premarket trading, reflecting investor optimism about the implications of such a shift. The move, if implemented, could alter the landscape for cannabis businesses and influence future legislative initiatives at both federal and state levels.
While the details and timeline of the reclassification process remain unclear, the development marks a notable moment in the evolving conversation around cannabis regulation in the United States. Further updates are expected as officials clarify the administration’s intentions and outline the next steps.